AbbVie updates EPS guidance to include IPR&D, milestones expense
…
173,570€
-1,00%
Echtzeit-Aktienkurs ABBVIE
Bid:
Ask:
Nachrichten zur ABBVIE Aktie
Ionis, AbbVie, Alnylam draw bullish views at Raymond James
…
Several layers to set up long-term growth for AbbVie - Raymond James By Investing.com
Several layers to set up long-term growth for AbbVie - Raymond James…
4 stocks to watch on Friday: Carnival Corp, AbbVie and more
…
AbbVie ends Caribou agreement on CAR-T therapy development
…
Optic Neuritis Treatment Market revenue to hit USD 450 Million by 2035, says Research Nester
Prominent Optic Neuritis Treatment Market players include Santen Pharmaceutical Co., Ltd., Mallinckrodt plc, AbbVie Inc., Novartis AG, Sanofi Group, AdvaCare…
Oncology Active Pharmaceutical Ingredient (API) Market revenue to reach USD 7 Billion by 2035, says Research Nester
Leading Oncology Active Pharmaceutical Ingredient (API) Market players include Sanofi, AbbVie Inc., Merck & Co. Inc., Pfizer Inc., Abbott Laboratories,…
Transforming Skin Care: Atopic Eczema Treatment Market Size Predicted to Flourish to USD 13 Billion by 2030, with a 7.14% CAGR
[219 + Pages Report] According to a market research study published by Zion Market Research, the demand analysis of Global…
IBD (Ulcerative Colitis and Crohns Disease) Treatment Market revenue to hit USD 36 Billion by 2033, says Research Nester
Leading IBD (Ulcerative Colitis and Crohns Disease) Treatment Market players include Bausch Health Companies Inc., AbbVie Inc., Novartis AG, Bristol…
AbbVie wird eine stabile Dividende auszahlen
Der amerikanische Pharmakonzern AbbVie Inc. (ISIN: US00287Y1091, NYSE: ABBV) wird eine Quartalsdividende von 1,48 US-Dollar je Aktie an seine Aktionäre…
AbbVie seeks US, EU approval for Skyrizi for ulcerative colitis
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
AbbVie Submits Applications For New Indication To FDA And EMA For Ulcerative Colitis
WASHINGTON (dpa-AFX) - Biopharmaceutical company AbbVie, Inc. (ABBV) announced Monday that it has submitted applications for a new indication to…
AbbVie Seeks U.S., Europe OK for Skyrizi in Ulcerative Colitis >ABBV
AbbVie Seeks U.S., Europe OK for Skyrizi in Ulcerative Colitis >ABBV...…
Investors Heavily Search AbbVie Inc. (ABBV): Here is What You Need to Know
Zacks.com users have recently been watching AbbVie (ABBV) quite a bit. Thus, it is worth knowing the facts that could…
The Zacks Analyst Blog Highlights Procter & Gamble, AbbVie, The Walt Disney, HSBC Holdings and Duke Energy
Procter & Gamble, AbbVie, The Walt Disney, HSBC Holdings and Duke Energy are part of the Zacks top Analyst Blog....…
Top Analyst Reports for Procter & Gamble, AbbVie & Walt Disney
Todays Research Daily features new research reports on 16 major stocks, including The Procter & Gamble Company (PG), AbbVie Inc.…
Can AbbVie (ABBV) Protect Revenues After Humira Patent Loss?
AbbVies (ABBV) newer products, Skyrizi and Rinvoq, are performing extremely well and have the potential to make up for lost…
This Is What Whales Are Betting On AbbVie
read more...…
AbbVie (ABBV) Gets EU Approval for Migraine Prevention Drug
Following the approval, AbbVies (ABBV) Aquipta is the first and the only oral CGRP receptor antagonist approved in the EU…
AbbVie wins EU clearance for migraine therapy
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Is AbbVie Still a Good Dividend Stock to Buy?
Find out if AbbVie can overcome sinking sales of its top-selling product....…
Form 10-Q AbbVie Inc. For: Jun 30
Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…
Is AbbVie Stock a Buy for Income Investors?
The pharmaceutical giant is forecasting a return to growth starting in 2024....…
Corporate News: Temedica GmbH
Temedica launcht in Kooperation mit AbbVie Deutschland einen digitalen Begleiter für PatientInnen mit chronisch-entzündlichen Darmerkrankungen...…
Better High-Yield Dividend Stock: AbbVie vs. Verizon Communications
Which of these high-yield dividend stocks is the better buy right now?...…
Pharma Stock Roundup: AZN, SNY, ABBV Q2 Results, MRK, MRNA Cancer Jab in Phase III
AstraZeneca (AZN), Sanofi (SNY) and AbbVie (ABBV) announce second-quarter results....…
AbbVie (ABBV) Q2 2023 Earnings Call Transcript
ABBV earnings call for the period ending June 30, 2023....…
Why AbbVie Stock Is Jumping Today
Humira isnt the only story for AbbVie these days....…
AbbVie Raises Earnings Outlook as Autoimmune Drugs Come In Strong
Sales of Skyriz and Rinvoq both rose by 50% or more from a year earlier, making up for continuing declines…
Compared to Estimates, AbbVie (ABBV) Q2 Earnings: A Look at Key Metrics
While the top- and bottom-line numbers for AbbVie (ABBV) give a sense of how the business performed in the quarter…
AbbVie (ABBV) Beats Q2 Earnings and Revenue Estimates
AbbVie (ABBV) delivered earnings and revenue surprises of 4.30% and 2.54%, respectively, for the quarter ended June 2023. Do the…
Inside AbbVie: Signs of stabilization in Humira sales?
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
AbbVie Boosts FY23 Outlook As Q2 Results Top Estimates
WASHINGTON (dpa-AFX) - While reporting financial results for the second quarter on Thursday, biopharmaceutical company AbbVie, Inc. (ABBV) trimmed its…
AbbVie shares climb after quarterly results beat expectations
AbbVie Inc. ABBV shares gained 1.5% premarket on Thursday after the pharmaceutical giant reported stronger-than-expected revenue for the second quarter…
AbbVie Q2 Profit Increases, beats estimates
WASHINGTON (dpa-AFX) - AbbVie (ABBV) released a profit for its second quarter that increased from last year and beat the…
Form 8-K AbbVie Inc. For: Jul 27
Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…
AbbVie raises annual profit forecast as Humira stays strong, new drugs impress
...(Reuters) - AbbVie on Thursday raised its annual profit forecast......…